Latest stories on CLRB
Cellectar Biosciences Bets on Iopofosine Breakthrough
TipRanks58 · neutralearnings
Cellectar Biosciences Announces Board Changes and New Director
TipRanks50 · neutralgeneral
Cellectar plans Phase III start in late Q4 2026 as it outlines potential WM approval in the second half of 2027
Seeking Alpha67 · bullishearnings
Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings